Vitamin D metabolism in nephrotic rats

Area of Science:

• Nephrology
• Endocrinology
• Biochemistry

Background:

• Patients with nephrotic syndrome often exhibit hypocalcemia despite elevated parathyroid hormone (PTH).
• This is presumed to result from low serum levels of 1,25(OH)2D, the active vitamin D metabolite, potentially due to urinary losses.
• The role of impaired renal conversion of 25(OH)D to 1,25(OH)2D in this condition remains unclear.

Purpose of the Study:

• To investigate the role of 1,25(OH)2D in the pathogenesis of nephrotic syndrome.
• To examine the renal conversion of 25(OH)D to 1,25(OH)2D in a rat model of nephrotic syndrome.
• To assess the renal response to PTH in nephrotic rats.

Main Methods:

• Nephrotic syndrome was induced in Sprague-Dawley rats using puromycin aminonucleoside (PAN).
• Rats received injections of 25(OH)D3 and PTH to assess their effects.
• Measurements included plasma calcium, serum vitamin D metabolites, serum PTH, renal 25(OH)D-1-hydroxylase activity, and nephrogenous cyclic AMP response to PTH.

Main Results:

• Nephrotic rats displayed lower plasma calcium, serum 25(OH)D, and serum 1,25(OH)2D compared to controls, with higher serum PTH.
• Administration of 25(OH)D3 partially corrected low calcium and 1,25(OH)2D levels in nephrotic rats.
• Despite elevated PTH, nephrotic rats showed reduced renal 25(OH)D-1-hydroxylase activity (Vmax) and a blunted nephrogenous cyclic AMP response to PTH.

Conclusions:

• Reduced serum 25(OH)D contributes to hypovitaminosis D in nephrotic rats.
• Impaired renal 1,25(OH)2D production and diminished renal responsiveness to PTH are present in nephrotic rats.
• These abnormalities suggest that impaired renal function and PTH signaling contribute to calcium metabolism disturbances in nephrotic syndrome.